KR
Insider
Kathleen A. Rickard
Chief Medical OfficerKathleen A. Rickard (Chief Medical Officer) filed 6 Form 4 reports in the past 24 months (0 purchases, 6 sales), most often in VRNA. The largest single filing was $1.2M of VRNA (240,000 sh × $4.90, as filed), executed Nov 25 2024. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
6
0 buys · 6 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$3.2M
shares × price, as filed
Last traded
Aug 1 2025
Filed Aug 5 2025
Volume by month
Buys $0
Sells $3.2M
Shares × price, as filed · by filing month · past 24 months
Most traded names
VRNA
VRNA
0 buys · 6 sells
6 filings
Recent filings
VRNASALE
Verona Pharma plc
View filing →
$767K58,336 sh × $13.14
Exec Aug 1 2025
Filed Aug 5 2025 · 5:30 PM ET VRNASALE Verona Pharma plc View filing → $1.0M
114,984 sh × $8.82
Exec May 6 2025
Filed May 8 2025 · 5:30 PM ET VRNASALE Verona Pharma plc View filing → $440K
49,200 sh across 2 lots
Exec May 1 2025
Filed May 5 2025 · 5:30 PM ET VRNASALE Verona Pharma plc View filing → $309K
34,384 sh × $8.98
Exec Apr 29 2025
Filed May 1 2025 · 5:30 PM ET VRNASALE Verona Pharma plc View filing → $662K
79,264 sh × $8.35
Exec Mar 12 2025
Filed Mar 13 2025 · 5:30 PM ET VRNASALE Verona Pharma plc View filing → $1.2M
240,000 sh × $4.90
Exec Nov 25 2024
Filed Nov 26 2024 · 5:30 PM ET